Patents Assigned to Metabolic Technologies, LLC
  • Publication number: 20250367146
    Abstract: The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time and enhanced soft tissue healing. Soft tissue trauma includes administration of a Botulinum toxin, such as Botox. Administration of HMB in association with administration of a Botulinum toxin increases muscle strength and/or function in muscle, including adjacent and/or contralateral muscles and prevents or lessens loss of contractile material.
    Type: Application
    Filed: January 27, 2025
    Publication date: December 4, 2025
    Applicant: Metabolic Technologies, LLC
    Inventors: Shawn Baier, Naji Abumrad, Emily Harris
  • Patent number: 12370159
    Abstract: The present invention provides a composition comprising HMB and at least one probiotic. Methods of administering HMB and at least one probiotic to an animal are also described. HMB and probiotics are administered to attenuate inflammatory cytokine markers and/or maintain muscle integrity.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: July 29, 2025
    Assignee: Metabolic Technologies, LLC
    Inventors: Jay Hoffman, John Rathmacher
  • Publication number: 20250057792
    Abstract: The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance or promote lipolysis, increase adipocyte fat oxidation, induce adipocyte and muscle mitochondrial biogenesis, increase energy expenditure, decrease total body weight and increase body fat loss.
    Type: Application
    Filed: November 4, 2024
    Publication date: February 20, 2025
    Applicant: Metabolic Technologies, LLC
    Inventors: John Rathmacher, Naji Abumrad, Shawn Baier
  • Patent number: 12208073
    Abstract: The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time and enhanced soft tissue healing. Soft tissue trauma includes administration of a Botulinum toxin, such as Botox. Administration of HMB in association with administration of a Botulinum toxin increases muscle strength and/or function in muscle, including adjacent and/or contralateral muscles and prevents or lessens loss of contractile material.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: January 28, 2025
    Assignee: Metabolic Technologies, LLC
    Inventors: Shawn Baier, Naji Abumrad, Emily Harris
  • Patent number: 12161654
    Abstract: The present invention provides a composition comprising an acidic formulation containing ?-hydroxy-?-methylbutyrate (HMB), preferably in the free acid form, Vitamin D and a stabilizing excipient, wherein the Vitamin D is stabilized against degradation.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: December 10, 2024
    Assignee: Metabolic Technologies, LLC
    Inventors: John Rathmacher, Martin Purpura
  • Patent number: 11547713
    Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: January 10, 2023
    Assignee: Metabolic Technologies, LLC
    Inventors: John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad